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Available online 13 October 2007Large, multi-site studies utilizing MRI-derived measures from multi-
ple scanners present an opportunity to advance research by pooling
data. On the other hand, it remains unclear whether or not the
potential confound introduced by different scanners and upgrades will
devalue the integrity of any results. Although there are studies of
scanner differences for the purpose of calibration and quality control,
the current literature is devoid of studies that describe the analysis of
multi-scanner data with regard to the interaction of scanner(s) with
effects of interest. We investigated a data-set of 136 subjects, 62
patients with mild to moderate Alzheimer's disease and 74 cognitively
normal elderly controls, with MRI scans from one center that were
acquired over 10 years with 6 different scanners and multiple upgrades
over time. We used a whole-brain voxel-wise analysis to evaluate the
effect of scanner, effect of disease, and the interaction of scanner and
disease for the 6 different scanners. The effect of disease in patients
showed the expected significant reduction of grey matter in the medial
temporal lobe. Scanner differences were substantially less than the
group differences and only significant in the thalamus. There was no
significant interaction of scanner with disease group. We describe the
rationale for concluding that our results were not confounded by
scanner differences. Similar analyses in other multi-scanner data-sets
could be used to justify the pooling of data when needed, such as in
studies of rare disorders or in multi-center designs.
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Techniques utilizing in vivo MRI-derived measures of brain
tissue morphometrics show increasing promise for aiding clinicians
in assessment and diagnosis of disease. Studies that use long-
itudinal and/or multi-site data-sets, such as the Alzheimer's Disease
Neuroimaging Initiative (Mueller et al., 2005), have the potential to
provide a wealth of information. The large numbers of subjects
resulting from pooling multi-scanner data-sets has numerous
advantages. It increases sensitivity thus allowing detection of
subtle effects and enables the analysis of subgroups within a
cohort. Additionally, pooling offers increased reliability and
confidence about the size of effect by averaging out unforeseen
confounds and hence a method for carrying out meta-analyses or
analyses of rare subjects with orphan-diseases scanned at home
rather than in distant centers. Any one study may have unforeseen
bias which is lessened by pooling. However, one important
confound of combining images gathered from different scanners is
the potential for scanner effects to introduce systematic error, thus
making the interpretation of results difficult. Partial volume effects
and image intensity inhomogeneity can introduce error into
automatic segmentation with any given scanner (Li et al., 2005).
Noise of the electronics of the MRI system, subject-specific
physiological noise and imaging gradient non-linearities also
contribute to image intensity variability (Jovicich et al., 2006;
Littmann et al., 2006). Furthermore, differences in subject
positioning between sites add to the variability in distortion fields
(Jovicich et al., 2006) and images can vary as a function of
protocol differences between a baseline and a later scan or with
drifts in instrument signal to noise over time (Preboske et al.,
2006). The interaction of scanner differences with segmentation
remains a particular concern and potential cause of varied measures
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2000). It is therefore vital to confirm that there is no important
interaction between scanner and effect of interest and/or account
for the effects of different scanners in a principled manner before
pooling from different scanners can be recommended as a routine.
The use of phantoms to calibrate different scanners and account
for scanner drift or upgrades is well established (Tofts, 1998; Van
Haren et al., 2003; Schnack et al., 2004; Jovicich et al., 2006) and a
useful way to guarantee quality. Studies using a small number of
healthy subjects repeatedly scanned on different scanners or after
upgrades are also recommended to test reliability (Tofts, 1998; Han
et al., 2006; Jovicich et al., 2006). However, it is not clear that the
extra calibration efforts can actually correct for the majority of
these sources of variability (Jovicich et al., 2006), or are even
necessary. Also, it has yet to be established how confidently the
results from multi-scanner data-sets can be interpreted irrespective
of up-front calibration.
Multi-scanner studies, though not common, are increasing. A
longitudinal aging study by Raz and colleagues, one of the few
which discussed the analysis of images derived from multiple
scanners, concluded that using different scanners in 4 subjects
did not affect measured intracranial volume with a manual
tracing method (Raz et al., 2005). Likewise, manual hippocam-
pal measurements performed on both 1.5 T and 3.0 T scanners
in 8 healthy controls were not affected by field strength
(Breillmann et al., 2001). We are not aware of any study that
has described an automated analysis of a large, multi-scanner
data-set with the aim of assessing whether scanner-associated
biases are significant.
We set out to investigate scanner effects in an automatically
preprocessed data-set of subjects with mild to moderate AD and
cognitively normal elderly people whose MRI scans had been
collected over a period of 10 years with multiple scanners and
upgrades on a consistent platform and repeated calibrations. Even
though the concern has been raised that segmentation errors are a
particular problem in atrophic brains (Good et al., 2002), we did
not find this to be an issue in our sample, possibly because the
disease was early. We hypothesized that the changes due to AD
pathology are large compared to scanner induced distortions and
that there would be no interaction of scanner with case and/or
control groups. In this paper, we report the results in our data-set
and outline a method by which multi-scanner data-sets might be
pooled with confidence.Table 1
Scanner and subject demographics (⁎)
Scanner Group MMSEa (range) Age (range) Se
1 Controls 28.6 (26–30) 75.1 (61–85) 4/
Patients 23.2 (17–27) 75.8 (63–87) 5/
2 Controls 29 (26–30) 78.6 (68–87) 6/
Patients 22.6 (15–29) 78.5 (68–92) 4/
3 Controls 28.7 (26–30) 80.1 (70–90) 3/
Patients 22.4 (15–27) 76.4 (61–88) 6/
4 Controls 29.0 (27–30) 72.1 (50–86) 7/
Patients 21.9 (18–27) 80.2 (54–91) 2/
5 Controls 29.3 (28–30) 70.4 (57–79) 4/
Patients 22 (17–29) 77.3 (66–83) 2/
6 Controls 27.7 (26–30) 78.7 (68–91) 2/
Patients 20.4 (17–24) 76.3 (71–85) 5/
a MMSE=Mini-Mental State Exam.Methods and results
Our data-set included a total of 6 scanners and 136 subjects
scanned over a 10-year period. None of the subjects were scanned
more than once. All scans were done on the same platform,
General Electric Signa 1.5 T scanners (slice thickness 1.6, matrix
dimensions 256×192). There were minor variations in the TR, TE,
and flip angle (see Table 1). Scanners also underwent upgrades
over time. Importantly, all scanners were monitored with daily
phantom quality checks which calibrated the gradients to within
±1 mm over a 200-mm volume centered at iso-center, monitored
signal to noise and radio frequency (RF) transmit gain. The major
hardware elements (body resonance module gradient coil and
birdcage head transmit–receive volume coil) were unchanged
throughout time and across scanners, except that for the oldest
scanner (scanner 2), the wiring in the resistive shim set was not
cooled to super conducting temperatures, whereas for the other 5
scanners, the shim coils were inside the dewar and were cooled to
the superconducting range.
We used voxel-based morphometry (VBM) to evaluate the
interaction of scanner and grey matter segmented modulated
images for the 6 different scanners. VBM has the advantage of
assessing the whole brain and not being biased to one particular
region or structure. It entails a voxel-wise comparison of local
volume of grey matter between groups after the images are
spatially normalized into the same space, segmented, modulated,
and smoothed. Voxel-wise statistical parametric maps result from
statistically thresholded contrasts after corrections for multiple
comparisons (Ashburner and Friston, 2000) using false discovery
rate (FDR) (Benjamini and Hochberg, 1995).
Images were visually inspected for artifacts or structural
abnormalities unrelated to AD. They were firstly segmented into
white (WM) and grey matter (GM) using SPM5 (Wellcome Trust
Centre for Neuroimaging, Institute of Neurology, UCL, London
UK – http://www.fil.ion.ucl.ac.uk/spm). Then, WM and GM
segments were further normalized to a population template
generated from the complete image set using a diffeomorphic
registration algorithm. This non-linear warping technique mini-
mizes structural variation between subjects (Ashburner, 2007). For
comparison, we also repeated the analysis using the more widely
used standard SPM5 segmentation code (Ashburner and Friston,
2005) instead of the diffeomorphic registration algorithm. Resolu-
tion before normalization was − .9, .9, 1.6 and after normalizationx (F/M) n TR TE Flip angle (deg)
13 17 17.5–27 6–10 25, 45
8 13 23–27 6–10 25, 45
3 9 24 9 45
13 17 24 9 45
6 9 23–25 9–10 25, 45
1 7 23–27 9–10 25, 45
17 24 23,25 6–10 25, 45
7 9 23 6–10 25
5 9 22,23 9.8,10 25
4 6 17.7–27 6–10 25, 45
4 6 17.6–27 6–10 25, 45
5 10 21–27 6–10 25, 45
Fig. 2. F-tests showing effect of disease group (AD vs. controls irrespective
of scanner), FDR threshold of pb0.001. Images are overlaid on a group
average. Colour bar reflects the F-values.
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−2.0, 2.0, 2.0 with the standard SPM5 procedure. A separate
‘modulation’ step (Ashburner and Friston, 2000) was used to
ensure that the overall amount of each tissue class was not altered
by the spatial normalization procedure. Modulation was performed
by multiplying the warped tissue probability maps by the Jacobian
determinant of the warp on a voxel-by-voxel basis, which
represents the relative volume ratio before and after warping, thus
allowing voxel intensities in the segmented grey matter map,
together with the size of the voxels, to reflect regional volume and
preserve total grey matter volume from before the warp. Modulated
grey matter scans were smoothed using a 6-mm full-width at half-
maximum Gaussian kernel.
The smoothed grey matter images were analyzed in a factorial
design, with the 6 different scanners as one factor (SCANNER)
with 6 levels and the presence of AD (GROUP) as the second
factor with two levels (present and absent). Age, gender, and total
intracranial volume were entered as covariates (Fig. 1). We
performed F-tests correcting for multiple comparisons across the
brain (FDR correction). The degrees of freedom was 121 for all
comparisons. The effect of group revealed strong effects (pb0.001)
in the left medial temporal lobe (−29, −24, −9 [x, y, z]; F=100.34)
and right medial temporal lobe (30, −27, −9 [x, y, z]; F=91.44)
(Fig. 2). The effect of scanner showed significant differences
(pb0.05) in the right (9, −30, 0 [x, y, z]; F=11.93) and left (−9,
−11, 8 [x, y, z]; F=9.69) thalami (Fig. 3), but this effect was less
than the effect of group. T-tests contrasting each scanner against the
others revealed the scanner effect in the thalamus was mostly due
to the oldest scanner (scanner 2). One newer scanner (scanner 6)
revealed an effect that did not survive FDR correction in the right
thalamus (8, −5, −3 [x, y, z]; T=4.03), whereas the oldest scanner
contrasted with the others revealed a significant effect (pb0.05) in
the left thalamus (−9, −11, 6 [x, y, z]; T=5.94). Despite the effect
of scanner, there was no significant interaction of scanner withFig. 1. Design matrix. Six scanners are separated by patients and controls,
i.e., scanner 1 normals, scanner 1 AD, scanner 2 normals, scanner 2 AD, etc.
Nuisance covariates include age, sex, and total intracranial volume (TIV).group, the highest Z-score being 3.82 with a corrected p value of
0.942. We performed F-tests for each possible combination of
scanners and found no significant interaction with any of these
groupings. When using the standard VBM procedure implemented
in SPM5 for normalization and segmentation, the results of theFig. 3. F-test showing effect of scanner (irrespective of cases or controls),
FDR threshold of pb0.05. Images are overlaid on a group average. Colour
bar reflects the F-values.
Fig. 4. Contrast estimates and 90% confidence intervals for: (A) Main effect of scanner in thalamus at [9, −30, 0; x, y, z] for contrasts of scanners 1 and 2;
scanners 2 and 3; scanners 3 and 4; scanners 4 and 5; scanners 5 and 6. (B) Main effect of group in thalamus at [9, −30, 0; x, y, z] for contrast of AD and controls.
(C) Main effect of group in medial temporal lobe at [−28.5, −24, −9; x, y, z] for contrast of AD and controls. (D) Main effect of scanner in medial temporal lobe
at [−28.5, −24, −9; x, y, z] for contrasts of scanners 1 and 2; scanners 2 and 3; scanners 3 and 4; scanners 4 and 5; scanners 5 and 6.
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diffeomorphic normalization/segmentation procedure. We failed to
find an interaction of scanner with group; the highest Z-score was
3.78 with an FDR corrected p value of 0.954. The effect of scanner
showed significant differences (pb0.05) in the left thalamus (−10,
−10, 6 [x, y, z]; F=9.49) and the right thalamus (8, −28, −4 [x, y,
z]; F=9.41). The effect of group also showed strong effects
(pb0.001) in the left medial temporal lobe (−26, −14, −20 [x, y, z];
F=101.46) and right medial temporal lobe (26, −8, −18 [x, y, z];
F=77.98).
Importantly, we found no significant scanner effects in the
medial temporal lobe cluster (−29,−24, −9 [x, y, z]; F=0.01) and
the disease effect size in the thalamus was minimal compared to the
effect size in the medial temporal lobe (9, −30, 0 [x, y, z]; F=1.06),
suggesting minimal scanner effects in the areas that are most
affected by AD and minimal disease effects in the areas showing
scanner differences. Confidence intervals, which are reflective of
the standard deviations, for the contrast estimates are shown in Fig.
4. At the voxel of greatest effect of group, the confidence interval
is small relative to the effect size for the main effect of group. Theopposite is true for the effect of scanner at the area of greatest
disease, which is further evidence of lack of effect. For the main
effect of scanner, confidence intervals are similar between the
different scanner contrasts (see Fig. 4A), indirectly suggestive of
relatively little variance across scanners.
Because there were 4 software upgrades, we also analyzed the
interaction of software version and disease. Using the same basic
design matrix as described for the interaction with scanners, this
time the contrasts included cases and controls from each software
version, covaried with age, gender and intracranial volume. As
with the effect of scanner, there was no significant interaction of
software version with group, the highest Z-score being 3.65 with a
corrected p value of 0.880.
Discussion
In our data-set, we found the effect of disease to be substantially
larger than the effect of scanner and failed to find a significant
interaction of disease with scanner or software upgrades. In general,
the effect of disease in AD is liable to be larger than the effect of
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between scanner and effect of interest. Ideally, further studies with
an even larger data set to better calculate the effect sizes and quantify
the distance between the scanner effect cluster and group effect
cluster could be done to validate our findings. However, comparison
of the magnitude of the scanner effect versus disease effect in the
medial temporal lobe cluster in our data-set demonstrates that
scanner differences had minimal effects in the areas that are
important in the study of AD. Furthermore, even though there are
likely to be some differences among data from different scanners,
our experiments were explicitly designed to detect scanner-related
differences. By modeling appropriate confounds in the design
matrix, it appears possible to remove these small effects. We were
able to model this interaction easily because relatively homogeneous
cases and controls were scanned in each machine. We are unable to
say whether lesser or more subtle and distributed changes would be
as resistant to scanner effects.
Thoughwe did not detect a significant interaction of scanner with
disease, we cannot be absolutely certain it is indeed due to the
absence of such effect. The lack of significance may be a reflection
of the lack of statistical power, e.g., insufficient number of scans.
Other causes such as a high average residual variance or residual
variance inhomogeneities could also under-power the detection of
the effects. However, the variance inhomogeneity was considered in
our analysis by assuming unequal variance for the different levels of
each of the two factors in our full factorial design (the two factors are
the scanner and group). In a post-hoc manner, we explored the
residual variance across scanners to assess whether that explained
the lack of sensitivity in the results. In the area of greatest disease
effect, the variance was low and did not reflect significant
inhomogeneity, but in the area of greatest scanner effect there was
lower average residual variance and more variability. Though our
tests for variance inhomogeneity across the 6 scanners was not
voxel-by-voxel over the whole brain volume, our findings seem to
support that the variance inhomogeneity is location-dependent and
should be accounted for when analyzing data acquired from different
scanners as we attempted to do in our analysis.
The greatest effect of scanner was in the thalamus. The effect of
the thalamus was largely driven by the scanner with the resistive
shim set that was not cooled to superconducting temperatures, which
suggests an impact of such hardware differences on thalamic
segmentation. The composition of the thalamus is an issue of debate
as it is not completely grey matter receiving numerous white matter
tracts from other parts of the brain. Additionally, the grey matter
intensity value of the thalamus is different from that of cortical grey
matter. The intrinsically poor intensity contrast in the thalamus
renders it susceptible to small differences in image contrast due to
scanner differences. There is also less variability in this part of the
brain, so tests will be more sensitive to such differences. These
factors may contribute to the difficulty of accurate segmentation of
the thalamus in addition to scanner effects.
The relatively small effect of scanner is potentially attributable to
quality control measures during data acquisition and/or the
robustness of the segmentation method. The SPM5 algorithm, by
using spatial information together with intensity information, should
be more robust to such differences than a segmentation algorithm
that is purely intensity-based. However, this study did not directly
investigate which forms of preprocessing are most affected by
scanner parameters. It is important to note, though, that the effect
was not due to the diffeomorphic normalization procedure, since we
obtained similar patterns to those with the standard SPM5 normal-ization. Presumably, the use of daily scanner calibrations allows for a
relatively constant intensity contrast between grey and white matter
voxels between scans. Routine procedures designed to minimize
image intensity differences over time are useful, particularly since it
has been demonstrated that several common scan functions can
potentially introduce measurement errors as high as 100% (i.e.,
much greater than the disease effect of AD), without appropriate
quality control measures in place (Preboske et al., 2006). Even
though it is common experience that current generation scanners are
remarkably stable over time, they do still drift in a way that is
correctable with judicious calibration. Though we collected no data
to determine the frequency and level of sophistication necessary,
basic calibration akin to the current standard in most major centers is
likely sufficient. Furthermore, while it can be useful to collect data
on inter-subject variability by scanning the same subjects in different
scanners, such efforts would not directly answer the question of
whether data from different subjects on different scanners can be
pooled.
The unified segmentation method of SPM5 (Ashburner and
Friston, 2005) produces an estimate of the tissue class intensities
from a fitting of spatial priors to the image, which allows for
differences in image intensities between scans. Additionally, any
image intensity differences due to subject to subject variation in
coupling of the RF coil to the head that may be introduced by
different head shapes and sizes are likely to be well-accounted for
by bias corrections in the unified segmentation algorithm.
As long as provision for different scanners and/or upgrades is
made within an analysis, the effect of scanner regardless of
magnitude is not likely to devalue the integrity of results. However,
if there is a true physical interaction of the biological effect of
interest with the method of measurement, perfect calibration or
even using a single scanner would not prevent bias. On the other
hand, any unusually large effect from one scanner would be
attenuated by the totality of scans from different scanners that
make up the template, which averages the different scanner effects
for normalization.
To date, methodological differences between individual studies
have prevented comprehensive pooling of data in meta-analyses of
AD MRI studies (Zakzanis et al., 2003; Whitwell and Jack, 2005;
Wahlund et al., 2005). To the extent that data pooling was possible,
the meta-analysis compared regional volume between disease
groups (Zakzanis et al., 2003). Although there may be concern
about error introduced by the variability inherent in preprocessing
many individuals across studies, automated VBM methods
successfully overcome the problems to combine information from
multiple scans and studies. VBM meta-analyses of pooled scans
permit the usual range of analyses beyond simple categorical
comparisons (e.g., regression, age interaction, subgroup, nonlinear,
etc.).
Our results suggest that for Alzheimer's disease, particularly if
the imaging platform remains constant, variations attributable to
individual scanners and upgrades may have negligible effects on
segmented grey matter images. We expect, though do not yet have
the data, that the approach is robust enough to accommodate using
both 1.5 T and 3 T scans in the same meta-analysis. A principled
approach to test the validity of a meta-analysis is to carry out an a
priori interaction analysis of scanner by biological effect to be
studied to exclude scanner-specific compromising effects. Addi-
tional comfort can be gained by finding that the biological effect is
of greater magnitude than any effect of scanner. An alternative
approach is to model each scanner's effects separately, thereby
1185C.M. Stonnington et al. / NeuroImage 39 (2008) 1180–1185permitting a principled meta-analysis on pooled data. That data can
be pooled from different scanners without corroding the integrity
of results is reassuring for large multi-site studies.
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